Definium Therapeutics, Inc.
USD22.86
-1.20 (-4.99%)
CEO
Robert Barrow
IPO Date
2016-11-15
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$23.55
Prev. Close
$24.06
Day Low
$22.15
Day High
$23.70
52W Low
$12.88
52W High
$26.15
Market Cap
$2.49B
Volume
2.11M
| 10,702 |
| $18.47 |
| 26 Mar 2026 | Barrow Robert | director, officer: Chief Executive Officer | S-Sale | Disposed | 24,431 | $18.47 |
| 5 Feb 2026 | Wiley Matthew T. | Chief Commercial Officer | A-Award | Acquired | 115,000 | $0.00 |
| 5 Feb 2026 | Roberts Brandi | Chief Financial Officer | A-Award | Acquired | 150,000 | $0.00 |
| 5 Feb 2026 | Sullivan Mark | Chief Legal Officer | A-Award | Acquired | 125,000 | $0.00 |
| 5 Feb 2026 | Karlin Daniel | Chief Medical Officer | A-Award | Acquired | 150,000 | $0.00 |
| 5 Feb 2026 | Barrow Robert | director, officer: Chief Executive Officer | A-Award | Acquired | 320,000 | $0.00 |
| 29 Jan 2026 | Adsett Roger | director | A-Award | Acquired | 50,000 | $17.24 |
| 29 Jan 2026 | Adsett Roger | — | Disposed | 0 | $0.00 |